Tumor microenvironment: a mechanical force link by unknown
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2015. This article is published with open access at link.springer.com life.scichina.com   link.springer.com 
                  
email: tjhuangbo@hotmail.com 
• INSIGHT • February 2015  Vol.58  No.2: 202–204 
 doi: 10.1007/s11427-014-4796-x  
Tumor microenvironment: a mechanical force link 
HUANG Bo 
State Key Laboratory of Medical Molecular Biology & Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of 
Medical Sciences & Peking Union Medical College, Beijing 100005, China 
Received December 10, 2014; accepted December 10, 2014; published online January 4, 2015 
 




The tumor microenvironment is created by tumor cells and 
molded by infiltrating immune cells. Both adaptive immune 
cells like T cells and B cells and innate immune cells such 
as macrophages, dendritic cells (DC), NK cells, granulo-
cytes, mast cells and immature myeloid cells are brought 
together to form a tumor immune microenvironment [1]. 
Although it is virtually taken for granted that the entry of 
immune cells to tumor microenvironment is a mechanistic 
process involving chemotaxis and extravasation, blood  
vessels are indeed a matter. And their real role in this pro-
cess is much complex than what we generally think at pre-
sent [2].  
Tumor blood vessels formed by angiogenesis or vascu-
logenesis show marked differences from normal blood ves-
sels with respect to both their structure and function [3]. 
Structurally, tumor blood vessels are tortuous and dilated, 
and they are distributed very heterogeneously with many 
areas lacking vasculature [4]. Moreover, tumor blood ves-
sels lack adequate pericytes coverings. Pericytes are located 
around endothelial cell junctions and form umbrella-like 
structures that cover endothelial gaps and maintain endothe-
lial integrity. Functionally, blood vessels are hyperpermea-
ble and blood flow is at times insufficient due to patchy 
hypoperfusion and leakage out of the blood vessels. Struc-
tural and functional abnormalities of tumor blood vessels 
result in hypoxia, acidity and high interstitial fluid pressure 
[5]. The hypoxic microenvironment stimulates the release of 
VEGF and the latter in turn further exacerbates the endothe-
lial permeability, leading to more blood leakage and wors-
ening interstitial hydrostatic pressure. Tumor interstitial 
pressure inevitably becomes a strong external force to pre-
vent immune cell entry. Therefore, an alternative strategy of 
targeting tumor vasculature, different from the current 
blockade one, is to ameliorate the formation of tumor vas-
cular networks, with normalized tumor blood vessels [6]. 
Normalized blood vessels will likely permit more cytotoxic 
immune cells to leave vessels and access to tumor paren-
chyma. A greater awareness of the concept of vessel nor-
malization will further stimulate interests in studying this 
process. 
Interstitial fluid homeostasis is normally maintained by 
lymph vessels collecting and transporting extracellular pro-
tein-rich fluid back to the hematic circulation [7]. High in-
terstitial pressure plus hypoxia significantly up-regulates the 
expression of VEGF-A, C and D in tumor microenviron-
ment. In turn, all these growth factors have the ability to 
induce tumor lymphangiogenesis. Compared to hematic 
flow, lymph flow may be much friendlier for tumor cell 
survival, due to its slow speed and absence of shear stress. 
Accordingly, lymphangiogenesis in tumor microenviron-
ment is thought to promote tumor metastasis, leading to the 
adaptation of blockage of lymphangiogenesis as a new 
weapon against tumor metastasis [8]. Although it may well 
inhibit, blocking lymphangiogenesis may also aggravate the 
interstitial fluid pressure. Thus, a too strong interstitial 
pressure may seriously prevent the extravasation of cyto-
toxic CTLs, NK cells and other immune cells that attack 
tumor cells. Even higher increased interstitial fluid pressure 
might facilitate tumor cells to intravasate tumor vessels for 
hematogenous metastasis. Chronic inflammation drives tu-
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mor initiation, progression and metastasis. Targeting tumor 
inflammatory microenvironment by non-steroid anti-   
inflammatory drugs, neutralizing antibodies of inflammato-
ry cytokines and small compounds against inflammation 
pathways have shown promise in tumor therapeutics. 
Blocking lymphangiogenesis may impede inflammation 
resolution, leading to worsened inflammation and tu-
mor-promoting results. In other words, targeting tumor 
lymphangiogenesis may well increase lymphangiogenesis 
rather than decrease it.  
Interstitial fluid pressure not only influences immune cell 
infiltration and tumor inflammation, but also changes tumor 
physical microenvironment. Tissue stiffness profoundly 
affects tumor cell behavior via biomechanical signaling 
pathways. This mechanical force is generated by the inter-
action between the extracellular matrix and cells and trans-
duced by integrins on the cells and their downstream micro-
filaments. It has been demonstrated that soft matrices (low 
density) are required for tumor stem maintenance and pro-
motion of tumor-repopulating cell growth; and stiffness 
matrices may promote the proliferation of differentiated 
tumor cells [9]. Interestingly, tumor tissue stiffness is very 
heterogeneous. Solid tumors are usually stiffer than their 
normal counterparts, also stiffer than immune organs such 
as bone marrow, spleen and lymph nodes. When immune 
cells migrate from soft immune organs to stiff tumor tissues, 
whether and how the altered mechanical signaling influ-
ences those immune cell functions remain unclear. We 
found that different matrix stiffness indeed conferred dif-
ferent phenotype and function in macrophages (unpublished 
data). When looking at tumor physical microenvironment, 
besides tissue stiffness, there are also compressive forces 
that need to be considered. In fact, tumor compressive forc-
es are probably mainly generated by interstitial fluid pres-
sures. Because of the heterogeneous distribution of tumor 
blood vessels, interstitial fluid pressures vary in different 
parts of tumor tissue, leading to heterogeneity of compres-
sive forces in a tumor. Because of the effect of compressive 
forces on neighboring matrix stiffness, interstitial fluid 
pressure may influences both compressive forces and tissue 
stiffness, thus remodeling the tumor physical microenvi-
ronment. Intriguingly, the application of compressive forces 
to embryonic stem cells results in auxetic nuclei [10]. Alt-
hough the underlying mechanism is unclear, it is reasonable 
to speculate that compressive forces induce DNA from 
condensed form to a loosened form, leading to auxetic nu-
clei. If it is true, asymmetric compressive forces also regu-
late gene expression. Therefore, interstitial fluid pressure is 
not a simple physical barrier for immune cell infiltration 
and inflammation resolution. It also affects tumor cells and 
immune cells through regulating their pulling and compres-
sive forces. To date, understanding the influence of tumor 
physical microenvironment on tumor-infiltrating immune 
cells remains completely unclear. Probably, now is the time 
to pilot this new area of tumor immunology.  
Currently, adaptive cell therapy (ACT) against cancer is 
an emerging field that shows promise in clinical trials. Ad-
vances in cell engineering and culture approaches make it to 
become a reality that chimeric T cell antigen receptor (CAR) 
T cells and tumor-specific T cells from TILs and PBMCs 
can be generated abundantly in vitro. However, these tu-
mor-killing cells have to face high tumor fluid pres-
sure-mediated entry barrier after adoptive transfer. Never-
theless, although normalizing tumor vasculature by low 
dose either anti-VEGFA antibody or radiation enhances the 
entry of adoptively transferred T cells, it is possible the 
combination of lymphangiogenesis-promoting method fur-
ther supports T cell entry into tumor. On the basis of the 
above analysis, we propose that the tumor vasculature is at 
the center of tumor microenvironment and act as a link be-
tween the tumor immune microenvironment and tumor 
physical microenvironment. The reciprocal interactions 
among tumor vasculature, immune microenvironment and 
physical microenvironment are summarized in a schematic 
(Figure 1). Elucidation of their cellular and molecular 
mechanisms must provide deep insight into new strategies 
on tumor therapeutics.  
 
 
Figure 1  Interactions of vasculature, immune microenvironment and 
physical microenvironment in tumor. 
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